Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells

Oncogene

Volumn 23, Issue 40, 2004, Pages 6712-6725

  Khanim, Farhat L ^a,c   Gommersall, Lyndon M ^a   Wood, Victoria H J ^a   Smith, Kirsty L ^a   Montalvo, Leire ^a   O'Neill, Laura P ^a   Xu, Yue ^b   Peehl, Donna M ^b   Stewart, Paul M ^a   Turner, Bryan M ^a   Campbell, Moray J ^a,c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

1 ,25 dihydroxyvitamin D 3; GADD45 ; Histone deacetylation inhibitors; Prostate cancer; SMRT

Indexed keywords

CELL PROTEIN; COLECALCIFEROL RECEPTOR; DIHYDROXYCOLECALCIFEROL; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ALIEN; PROTEIN APK2; PROTEIN KINASE; PROTEIN NCOR1; PROTEIN SMRT; REPRESSOR PROTEIN; SMALL INTERFERING RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; EPIGENETICS; GENE DISRUPTION; GENE EXPRESSION REGULATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; RECEPTOR BINDING; REPRESSOR GENE; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

BASE SEQUENCE; CALCITRIOL; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; DNA PRIMERS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING;

EID: 4644309396     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207772     Document Type: Article

References (74)

1. Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ and White JH. (2001). Mol. Endocrinol., 15, 1127-1139.
2. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW and Pinkel D. (2000). Nat. Genet., 25, 144-146.
3. Alsayed Y, Uddin S, Mahmud N, Lekmine F, Kalvakolanu DV, Minucci S, Bokoch G and Platanias LC. (2001). J. Biol. Chem., 276, 4012-4019.
4. Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA and Henner WD. (2003). J. Clin. Oncol., 21, 123-128.
5. Belandia B and Parker MG. (2003). Cell, 114, 277-280.
6. Blutt SE, Allegretto EA, Pike JW and Weigel NL. (1997). Endocrinology, 138, 1491-1497.
7. Blutt SE, Polek TC, Stewart LV, Kattan MW and Weigel NL. (2000). Cancer Res., 60, 779-782.
8. Campbell MJ, Elstner E, Holden S, Uskokovic M and Koeffler HP. (1997). J. Mol. Endocrinol., 19, 15-27.
9. Campbell MJ, Gombart AF, Kwok SH, Park S and Koeffler HP. (2000). Oncogene, 19, 5091-5097.
10. Campbell MJ, Park S, Uskokovic MR, Dawson MI and Koeffler HP. (1998). Endocrinology, 139, 1972-1980.
11. Chen TC and Holick MF. (2003). Trends Endocrinol. Metab., 14, 423-430.
12. Cohen LA, Marks PA, Rifkind RA, Amin S, Desai D, Pittman B and Richon VM. (2002). Anticancer Res., 22, 1497-1504.
13. Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW and Carlberg C. (1997). J. Cell. Biochem., 66, 552-562.
14. DeFouw LM and DeFouw DO. (2000). Tissue Cell, 32, 238-242.
15. Dwivedi PP, Hii CS, Ferrante A, Tan J, Der CJ, Omdahl JL, Morris HA and May BK. (2002). J. Biol. Chem., 277, 29643-29653.
16. Dwivedi PP, Omdahl JL, Kola I, Hume DA and May BK. (2000). J. Biol. Chem., 275, 47-55.
17. Feldman BJ and Feldman D. (2001). Nat. Rev. Cancer, 1, 34-45.
18. Germain P, Iyer J, Zechel C and Gronemeyer H. (2002). Nature, 415, 187-192.
19. Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE and Robson CN. (2001). Br. J. Cancer, 85, 1928-1936.
20. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S and Pelicci PG. (1998). Nature, 391, 815-818.
21. Guenther MG, Barak O and Lazar MA. (2001). Mol. Cell. Biol., 21, 6091-6101.
22. Hanchette CL and Schwartz GG. (1992). Cancer, 70, 2861-2869.
23. Hermanson O, Glass CK and Rosenfeld MG. (2002). Trends Endocrinol. Metab., 13, 55-60.
24. Hirose T, Sowa Y, Takahashi S, Saito S, Yasuda C, Shindo N, Furuichi K and Sakai T. (2003a). Oncogene, 22, 7762-7773.
25. Hirose T, Sowa Y, Takahashi S, Saito S, Yasuda C, Shindo N, Furuichi K and Sakai T. (2003b). Oncogene, 22, 7762-7773.
26. Hudelist G, Czerwenka K, Kubista E, Marton E, Pischinger K and Singer CF. (2003). Breast Cancer Res. Treat., 78, 193-204.
27. Ingles SA, Coetzee GA, Ross RK, Henderson BE, Kolonel LN, Crocitto L, Wang W and Haile RW. (1998). Cancer Res., 58, 1620-1623.
28. Jiang F, Li P, Fornace Jr AJ, Nicosia SV and Bai W. (2003a). J. Biol. Chem., 278, 48030-48040.
29. Jiang WG, Douglas-Jones A and Mansel RE. (2003b). Int. J. Cancer, 106, 752-757.
30. Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, Alomo I, Rajasekaran B and Zhan Q. (2001). Oncogene, 20, 2683-2690.
31. Jin S, Mazzacurati L, Zhu X, Tong T, Song Y, Shujuan S, Petrik KL, Rajasekaran B, Wu M and Zhan Q. (2003). Oncogene, 22, 8536-8540.
32. Kawashima H, Takano H, Sugita S, Takahara Y, Sugimura K and Nakatani T. (2003). Biochem. J., 369, 163-171.
33. Kollara A, Kahn HJ, Marks A and Brown TJ. (2001). Breast Cancer Res. Treat., 67, 245-253.
34. Konety BR, Schwartz GG, Acierno Jr JS, Becich MJ and Getzenberg RH. (1996). Cell Growth Differ., 7, 1563-1570.
35. Krishnan AV, Peehl DM and Feldman D. (2003). Recent Results Cancer Res., 164, 205-221.
36. Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I and Koeffler HP. (1998). Cancer Res., 58, 3370-3375.
37. Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH and Evans RM. (1998). Nature, 391, 811-814.
38. Liu M, Lee MH, Cohen M, Bommakanti M and Freedman LP. (1996). Genes Dev., 10, 142-153.
39. Ly LH, Zhao XY, Holloway L and Feldman D. (1999). Endocrinology, 140, 2071-2076.
40. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M and Gannon F. (2003). Cell, 115, 751-763.
41. Miller CW, Morosetti R, Campbell MJ, Mendoza S and Koeffler HP. (1997). Mol. Carcinogen., 19, 254-257.
42. Miller GJ, Stapleton GE, Hedlund TE and Moffat KA. (1995). Clin. Cancer Res., 1, 997-1003.
43. Mori T, Anazawa Y, Matsui K, Fukuda S, Nakamura Y and Arakawa H. (2002). Neoplasia, 4, 268-274.
44. Munker R, Norman A and Koeffler HP. (1986). J. Clin. Invest., 78, 424-430.
45. Oda Y, Sihlbom C, Chalkley RJ, Huang L, Rachez C, Chang CP, Burlingame AL, Freedman LP and Bikle DD. (2003). Mol. Endocrinol., 17, 2329-2339.
46. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M and Munoz A. (2001). J. Cell Biol., 154, 369-387.
47. Peehl DM. (2004). J. Cell. Biochem., 91, 185-195.
48. Peehl DM and Feldman D. (2003). Endocr. Relat. Cancer, 10, 131-140.
49. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA and Feldman D. (1994). Cancer Res., 54, 805-810.
50. Planas-Silva MD, Shang Y, Donaher JL, Brown M and Weinberg RA. (2001). Cancer Res., 61, 3858-3862.
51. Polek TC, Stewart LV, Ryu EJ, Cohen MB, Allegretto EA and Weigel NL. (2003). Endocrinology, 144, 50-60.
52. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T and Carlberg C. (2000). FASEB J., 14, 1455-1463.
53. Quack M and Carlberg C. (1999). Mol. Pharmacol., 55, 1077-1087.
54. Rachez C and Freedman LP. (2000). Gene, 246, 9-21.
55. Rachez C, Gamble M, Chang CP, Atkins GB, Lazar MA and Freedman LP. (2000). Mol. Cell. Biol., 20, 2718-2726.
56. Rashid SF, Moore JS, Walker E, Driver PM, Engel J, Edwards CE, Brown G, Uskokovic MR and Campbell MJ. (2001a). Oncogene, 20, 1860-1872.
57. Rashid SF, Mountford JC, Gombart AF and Campbell MJ. (2001b). Steroids, 66, 433-440.
58. Ratnam AV, Bikle DD, Su MJ and Pillai S. (1996). J. Invest. Dermatol., 106, 522-525.
59. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J and Gannon F. (2003b). Mol. Cell, 11, 695-707.
60. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J and Gannon F. (2003a). Mol. Cell, 11, 695-707.
61. Schmid HP and McNeal JE. (1992). Am. J. Surg. Pathol., 16, 184-191.
62. Schwartz GG, Wang MH, Zang M, Singh RK and Siegal GP. (1997). Cancer Epidemiol. Biomarkers Prev., 6, 727-732.
63. Sommerville J, Baird J and Turner BM. (1993). J. Cell Biol., 120, 277-290.
64. Tong WM, Bises G, Sheinin Y, Ellinger A, Genser D, Potzi R, Wrba F, Wenzl E, Roka R, Neuhold N, Peterlik M and Cross HS. (1998). Int. J. Cancer, 75, 467-472.
65. Wang DF, Wiest O, Helquist P, Lan-Hargest HY and Wiech NL. (2004). Bioorg. Med. Chem. Lett., 14, 707-711.
66. Wang X, Rao J and Studzinski GP. (2000). Exp. Cell Res., 258, 425-437.
67. Yamashita Y, Shimada M, Harimoto N, Rikimaru T, Shirabe K, Tanaka S and Sugimachi K. (2003). Int. J. Cancer, 103, 572-576.
68. Yoshida M, Horinouchi S and Beppu T. (1995). Bioessays, 17, 423-430.
69. Yu J, Li Y, Ishizuka T, Guenther MG and Lazar MA. (2003). EMBO J., 22, 3403-3410.
70. Zhang C, Baudino TA, Dowd DR, Tokumaru H, Wang W and MacDonald PN. (2001). J. Biol. Chem., 276, 40614-40620.
71. Zhu WG and Otterson GA. (2003). Curr. Med. Chem. Anticancer Agents, 3, 187-199.
72. Zhuang SH, Schwartz GG, Cameron D and Burnstein KL. (1997). Mol. Cell Endocrinol., 126, 83-90.
73. Zierold C, Mings JA, Prahl JM, Reinholz GG and DeLuca HF. (2002). Arch. Biochem. Biophys., 404, 18-24.
74. Zinser G, Packman K and Welsh J. (2002). Development, 129, 3067-3076.